JP2008532967A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008532967A5 JP2008532967A5 JP2008500134A JP2008500134A JP2008532967A5 JP 2008532967 A5 JP2008532967 A5 JP 2008532967A5 JP 2008500134 A JP2008500134 A JP 2008500134A JP 2008500134 A JP2008500134 A JP 2008500134A JP 2008532967 A5 JP2008532967 A5 JP 2008532967A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pharmaceutical composition
- cannabinoid receptor
- naphthalene derivative
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0504950.7A GB0504950D0 (en) | 2005-03-10 | 2005-03-10 | Organic compositions |
| PCT/EP2006/002245 WO2006094829A1 (en) | 2005-03-10 | 2006-03-10 | Microemulsions of cannabinoid receptor binding compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008532967A JP2008532967A (ja) | 2008-08-21 |
| JP2008532967A5 true JP2008532967A5 (enExample) | 2009-04-23 |
Family
ID=34508852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008500134A Pending JP2008532967A (ja) | 2005-03-10 | 2006-03-10 | カンナビノイド受容体結合化合物のマイクロエマルジョン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080279940A1 (enExample) |
| EP (3) | EP2305215A1 (enExample) |
| JP (1) | JP2008532967A (enExample) |
| KR (1) | KR20070117578A (enExample) |
| CN (1) | CN101137348A (enExample) |
| AU (1) | AU2006222117B2 (enExample) |
| BR (1) | BRPI0609023A2 (enExample) |
| CA (1) | CA2599251A1 (enExample) |
| GB (1) | GB0504950D0 (enExample) |
| MX (1) | MX2007011016A (enExample) |
| RU (1) | RU2007137182A (enExample) |
| WO (1) | WO2006094829A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011513278A (ja) * | 2008-02-28 | 2011-04-28 | ノバルティス アーゲー | カンナビノイド受容体結合化合物およびオピオイドを含む組合せ |
| JO3337B1 (ar) | 2010-12-13 | 2019-03-13 | Debiopharm Sa | تركيبات صيدلية تشمل أليسبوريفير |
| MX395015B (es) * | 2014-12-12 | 2025-03-24 | Ojai Energetics Pbc | Composiciones microencapsuladas de cannabinoides |
| US10350165B2 (en) | 2014-12-12 | 2019-07-16 | Ojai Energetics Pbc | Methods and systems for forming stable droplets |
| GB2551986A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Parenteral formulations |
| GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
| IL248150B (en) * | 2016-09-29 | 2018-05-31 | Garti Nissim | Method for selective extraction of cannabinoids from a plant source |
| IL248148B (en) | 2016-09-29 | 2021-09-30 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | A method for extracting a compound from plant origin |
| IL248149B (en) * | 2016-09-29 | 2020-03-31 | Garti Nissim | Formulations of dilutable cannabinoids and processes for their preparation |
| GB2559774B (en) | 2017-02-17 | 2021-09-29 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2569961B (en) * | 2018-01-03 | 2021-12-22 | Gw Res Ltd | Pharmaceutical |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1274354A (fr) | 1956-03-10 | 1961-10-27 | Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol | |
| KR0148748B1 (ko) | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
| GB9113872D0 (en) | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
| FR2697040B1 (fr) | 1992-10-21 | 1994-12-30 | Ind Entreprise | Elément de protection contre le bruit et son utilisation. |
| IL129547A (en) | 1994-10-26 | 2001-01-11 | Novartis Ag | Pharmaceutical compositions comprising a macrolide and an acid |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| GB0008785D0 (en) * | 2000-04-10 | 2000-05-31 | Novartis Ag | Organic compounds |
| GB0012795D0 (en) * | 2000-05-25 | 2000-07-19 | Novartis Ag | Organic compounds |
| US6623765B1 (en) * | 2000-08-01 | 2003-09-23 | University Of Florida, Research Foundation, Incorporated | Microemulsion and micelle systems for solubilizing drugs |
| GB0028702D0 (en) * | 2000-11-24 | 2001-01-10 | Novartis Ag | Organic compounds |
-
2005
- 2005-03-10 GB GBGB0504950.7A patent/GB0504950D0/en not_active Ceased
-
2006
- 2006-03-10 MX MX2007011016A patent/MX2007011016A/es not_active Application Discontinuation
- 2006-03-10 RU RU2007137182/15A patent/RU2007137182A/ru not_active Application Discontinuation
- 2006-03-10 US US11/908,216 patent/US20080279940A1/en not_active Abandoned
- 2006-03-10 EP EP10178526A patent/EP2305215A1/en not_active Withdrawn
- 2006-03-10 WO PCT/EP2006/002245 patent/WO2006094829A1/en not_active Ceased
- 2006-03-10 AU AU2006222117A patent/AU2006222117B2/en not_active Ceased
- 2006-03-10 BR BRPI0609023-0A patent/BRPI0609023A2/pt not_active IP Right Cessation
- 2006-03-10 EP EP06723358A patent/EP1858484A1/en not_active Withdrawn
- 2006-03-10 CA CA002599251A patent/CA2599251A1/en not_active Abandoned
- 2006-03-10 EP EP09151789A patent/EP2065033A1/en not_active Withdrawn
- 2006-03-10 KR KR1020077020512A patent/KR20070117578A/ko not_active Withdrawn
- 2006-03-10 CN CNA2006800076288A patent/CN101137348A/zh active Pending
- 2006-03-10 JP JP2008500134A patent/JP2008532967A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5047285B2 (ja) | シームレスカプセル | |
| CN104981253B (zh) | 固溶体组合物及其在慢性炎症中的用途 | |
| JP2013508296A5 (enExample) | ||
| JP2009502950A (ja) | ジヒドロピリジンカルシウムチャネルブロッカー及びω３脂肪酸を用いた治療法、並びにそれらの混合生成物 | |
| JP2013503174A5 (enExample) | ||
| CN101015524B (zh) | 辅酶q10口服乳剂及其制备方法 | |
| JP2013521310A5 (enExample) | ||
| EP0378086B1 (de) | Verwendung des Wirkstoffs Azelastin zur Bekämpfung von Psoriasis-Erkrankungen | |
| JP2009513669A5 (enExample) | ||
| RU2012120388A (ru) | Фармацевтические композиции, включающие производное камптотецина | |
| JP2017523142A5 (enExample) | ||
| CN102711735A (zh) | 治疗心血管疾病的、活性药物成分与多不饱和脂肪酸酯的胶囊 | |
| JP2008532967A5 (enExample) | ||
| JP2012525409A5 (enExample) | ||
| JP2013545752A5 (enExample) | ||
| EP2083802A2 (en) | Treatment with antiarrhythmics and omega-3 fatty acids and a combination product thereof | |
| JP2013522230A5 (enExample) | ||
| JP2003508484A5 (enExample) | ||
| CN1197388A (zh) | 用于口服给药的药物组合物 | |
| JP5328992B2 (ja) | 封入のためのロラタジンの医薬製剤およびその組合せ | |
| JP2001521894A (ja) | アルテミニシニン及び／又はアルテミシニン誘導体を含有する製薬学的活性組成物 | |
| JP2021075563A (ja) | １５−オキソ−ｅｐａまたは１５−オキソ−ｄｇｌａを含む組成物、ならびにその作製及び使用方法 | |
| EP0277352B1 (de) | Synergistische Kombination von Azelastin und Theophyllin oder Azelastin und Beta-Mimetika | |
| RU2007137182A (ru) | Микроэмульсии соединений, связывающихся с каннабиноидными рецепторами | |
| JP2013545802A5 (enExample) |